<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25103" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Microcystic Adnexal Carcinoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zito</surname>
            <given-names>Patrick M.</given-names>
          </name>
          <aff>University of Miami; Miller School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mazzoni</surname>
            <given-names>Thomas</given-names>
          </name>
          <aff>Cooperman Barnabas Medical Center/Rutgers University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Patrick Zito declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thomas Mazzoni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25103.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Microcystic adnexal carcinoma is a slow-growing, locally aggressive sweat gland tumor that is more commonly found on the head and neck. This activity reviews the evaluation and treatment of abdominal abscesses and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of microcystic adnexal carcinoma.</p></list-item><list-item><p>Outline the typical presentation of a patient with microcystic adnexal carcinoma.</p></list-item><list-item><p>Explain the importance of monitoring for patients following a diagnosis of microcystic adnexal carcinoma.</p></list-item><list-item><p>Review the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients with microcystic adnexal carcinoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25103&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25103">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25103.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Microcystic adnexal carcinoma (MAC) is a rare malignant sweat gland tumor that commonly occurs on the head and neck. MAC has a&#x000a0;predilection for the central face but may be found&#x000a0;although it may be found on the trunk, axilla, extremities, and genitals.&#x000a0;MAC is characterized by its&#x000a0;slow growth&#x000a0;but local aggressiveness.<xref ref-type="bibr" rid="article-25103.r1">[1]</xref></p>
        <p>There are approximately 200 cases worldwide; however, it was Goldstein and others that first described MAC in 1982.&#x000a0;</p>
        <p>MAC has been mentioned under a number of names, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sclerosing sweat duct carcinoma (SSDC)</p>
          </list-item>
          <list-item>
            <p>Malignant syringoma</p>
          </list-item>
          <list-item>
            <p>Syringoid eccrine carcinoma</p>
          </list-item>
          <list-item>
            <p>Eccrine epithelioma</p>
          </list-item>
          <list-item>
            <p>Syringomatous carcinoma</p>
          </list-item>
          <list-item>
            <p>Sweat gland carcinoma with syringomatous features</p>
          </list-item>
        </list>
        <p>The tumor, known as syringomatous adenoma of the nipple, has been considered MAC; however, this is debated. MAC is known to have perineural invasion (upwards of 80%) with infiltration beyond clinically apparent margins. However, it has little metastatic potential but often recurs.</p>
      </sec>
      <sec id="article-25103.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Risk factors have been identified for forming MAC:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ultraviolet (UV) radiation</p>
          </list-item>
          <list-item>
            <p>Previous radiation therapy</p>
          </list-item>
          <list-item>
            <p>Immunosuppressive medications</p>
          </list-item>
        </list>
        <p>The estimate for the link to therapeutic radiation ranges from 19% to 50%, with an average latent period of 30 to 40 years. UV radiation is often implicated&#x000a0;because most lesions appear in sun-exposed areas and those with Fitzpatrick skin types I and II.</p>
        <p>Microcystic adnexal carcinoma has also been reported in younger individuals with a history of additional UV exposure, such as fighter pilots.<xref ref-type="bibr" rid="article-25103.r2">[2]</xref></p>
        <p>The effect of immunosuppression on the risk for the development of MAC is unclear at this time, although immunosuppression increases the risk of basal cell carcinoma and squamous cell carcinoma.</p>
      </sec>
      <sec id="article-25103.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>MAC&#x000a0;tends to occur in adults 55 to 60 years old. However, it occasionally has occurred in children. Microcystic adnexal carcinoma arises&#x000a0;equally in males and females although some literature lists a slight female predominance.<xref ref-type="bibr" rid="article-25103.r3">[3]</xref></p>
      </sec>
      <sec id="article-25103.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Microcystic adnexal carcinoma often grows slowly and will present as a white to pink plaque located on the face. Often, it has been overlooked or ignored. Often it is confused with a basal cell carcinoma clinically. In such an instance, a shave biopsy is usually performed. However, in the case of microcystic adnexal carcinoma, the pathology lies deeper than a superficial shave biopsy will show. Thus, making the diagnosis more difficult. If suspected, a punch biopsy should be performed.</p>
      </sec>
      <sec id="article-25103.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, MAC can mimic infiltrative/morpheaform basal cell carcinoma, desmoplastic squamous cell carcinoma, desmoplastic trichoepithelioma, trichoadenoma, and syringoma.&#x000a0;</p>
        <p>Histopathological examination reveals small basaloid cells/keratocysts on the top, hence the term &#x0201c;microcystic.&#x0201d; This is a key feature.&#x000a0;On higher power, one can see cords and strands of basaloid epitheloid cells displaying ductal lumina that invade the dermis and subdermis.&#x000a0;There is also fibrotic stroma. A key feature in distinguishing MAC from other tumors is a zone of separation between the epidermis and tumor. Additionally, the ductal structures distinguish MAC from desmoplastic trichoepithelioma and trichoadenoma.</p>
        <p>MAC is distinguished from morpheaform basal cell carcinoma and desmoplastic squamous cell carcinoma based on ductal differentiation.</p>
        <p>
<bold>Immunohistochemistry</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Immunohistochemistry (IHC) is utilized in the pathologic evaluation of MAC to help support the diagnosis. In particular, the carcinoembryonic antigen stain (CEA) is positive in approximately 50% of MAC cases. This helps distinguish MAC from basal cell carcinoma and squamous cell carcinoma, where CEA is negative.</p>
          </list-item>
        </list>
        <p>
<bold>Stains</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hematoxylin and eosin (H&#x00026;E) stain is the standard stain used in the diagnosis of MAC.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25103.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Microcystic adnexal carcinoma is a solitary white to pink plaque located on the face or trunk. In the case of early tumors, the appearance may be slightly elevated; however, a more nodular appearance tends to develop with time.</p>
      </sec>
      <sec id="article-25103.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>MAC often may be clinically indistinguishable from other skin-colored growths on the head and neck.&#x000a0;MAC may have perineural spread where patients can complain of numbness, tingling, pain, burning, and itching sensations. The key to</p>
        <p>diagnosis is taking an appropriate pathology specimen is needed, and the key to diagnosis. The tumor largely lies within the deep dermis. A superficial biopsy can lead to an incorrect diagnosis. If MAC is suspected, avoid a superficial shave biopsy.</p>
        <p>An incisional biopsy is recommended in the evaluation. However, punch biopsies and excisional biopsies are options in evaluation.</p>
        <p>
<bold>Full Skin Examination</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>If a biopsy results in a diagnosis of MAC, a full-body skin examination should take place.</p>
          </list-item>
        </list>
        <p>
<bold>Lymph Nodes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Lymph node examination should be performed to assess for regional metastases, albeit rare.</p>
          </list-item>
          <list-item>
            <p>Fine needle aspiration (FNA) or excisional biopsy of enlarged lymph nodes should be performed if detected on examination.</p>
          </list-item>
        </list>
        <p>
<bold>Imaging</bold>
</p>
        <p>Consider the need for imaging (CT or MRI) or fat-suppression MRI protocol for perineural invasion&#x000a0;or intraorbital tumors.<xref ref-type="bibr" rid="article-25103.r4">[4]</xref></p>
        <p>
<bold>Dermoscopy</bold>
</p>
        <p>Dermoscopy does not offer a definitive diagnosis of MAC. MAC is a rare tumor, so dermoscopic findings are limited to case reports with the most characteristic finding appears to be the presence of whitish clods of variable size. These whitish clods likely representing keratinous cyst.<xref ref-type="bibr" rid="article-25103.r5">[5]</xref><xref ref-type="bibr" rid="article-25103.r6">[6]</xref><xref ref-type="bibr" rid="article-25103.r7">[7]</xref>&#x000a0;MAC&#x000a0;can appear&#x000a0;like a basal cell carcinoma due to the presence of arborizing vessels&#x000a0;reported in case literature.<xref ref-type="bibr" rid="article-25103.r8">[8]</xref></p>
      </sec>
      <sec id="article-25103.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>MAC is managed surgically by simple excision or Mohs micrographic surgery (MMS). Complication rates between MMS&#x000a0;and simple excision&#x000a0;are similar. When utilizing MMS, clear margins were obtained in fewer procedures and resulted in fewer office visits.<xref ref-type="bibr" rid="article-25103.r9">[9]</xref></p>
        <p>In the event that Mohs micrographic surgery is not an option due to lack of procedure availability or tumor extent, intraoperative frozen sections may be useful for guiding conventional surgical excision.</p>
        <p>Patients should be followed every six to twelve months following diagnosis and management for full-body skin examination and lymph node examination.</p>
      </sec>
      <sec id="article-25103.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>MAC presents often on the face as a&#x000a0;papule or plaque. The differential can be large. However, the differential diagnosis where MAC must be distinguished from is morpheaform basal cell carcinoma, desmoplastic squamous cell carcinoma, desmoplastic trichoepithelioma, trichoadenoma, and syringoma.<xref ref-type="bibr" rid="article-25103.r3">[3]</xref></p>
      </sec>
      <sec id="article-25103.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <list list-type="bullet">
          <list-item>
            <p>Sentinel lymph node&#x000a0;biopsy (SLNB) is not recommended for the staging of MAC as per the current evidence-based clinical practice guidelines.<xref ref-type="bibr" rid="article-25103.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Evidence is lacking that&#x000a0;supports neck dissection for a positive lymph node at presentation.</p>
          </list-item>
          <list-item>
            <p>Node positive&#x000a0;and metastatic disease should be treated surgically&#x000a0;as per the local disease.<xref ref-type="bibr" rid="article-25103.r2">[2]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25103.s12" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>The role of radiation therapy for microcystic adnexal carcinoma remains unclear. Monotherapy with radiotherapy is not recommended. According to the latest evidence-based clinical practice guidelines for MAC, adjuvant radiotherapy can be considered for MAC when there is peripheral nerve involvement, when margins and unable to be cleared surgically, or when there is a tumor present at the margins. Although, there have been reports of chemoradiation with carboplatin/paclitaxel combination used in a patient refusing surgical management that remained tumor-free for six years.<xref ref-type="bibr" rid="article-25103.r10">[10]</xref></p>
        <p>Prophylactic radiotherapy of the sentinel node base is not supported by current evidence.<xref ref-type="bibr" rid="article-25103.r4">[4]</xref></p>
      </sec>
      <sec id="article-25103.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The major prognostic concern for MAC is the recurrence of the tumor. Recurrence is generally seen within two to three years; however, it may occur even decades later.<xref ref-type="bibr" rid="article-25103.r11">[11]</xref>&#x000a0;MAC is a locally aggressive tumor whereas metastases are generally rare. Death may result from the invasion of vital structures.</p>
      </sec>
      <sec id="article-25103.s14" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of untreated tumors are locally aggressive invasion. Depending on location, complications can result from the invasion of vital structures. In some instances, death has resulted.</p>
      </sec>
      <sec id="article-25103.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated that MAC is a slow-growing tumor. Patients should be educated on the importance of follow-up examinations, and that recurrence may even occur&#x000a0;decades later in some instances.</p>
      </sec>
      <sec id="article-25103.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Microcystic adnexal carcinoma is a malignant tumor of sweat gland origin found primarily on the head and neck. An appropriate biopsy technique is key in establishing the correct diagnosis. Mohs micrographic surgery should be considered first-line surgical management in its ability to analyze the entire surgical margin intraoperatively.</p>
      </sec>
      <sec id="article-25103.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Microcystic adnexal carcinoma frequently poses a diagnostic dilemma.&#x000a0;These patients may note a long history of a papule or plaque on the head and neck. Physical examination of the skin may reveal tumor presence; however, accurate diagnosis depends on proper biopsy technique with a raised index of suspicion. While a dermatologist is almost always involved in the care of patients with microcystic adnexal carcinoma, it is important to consult with an interprofessional team of specialists that include a Mohs surgeon, an otolaryngologist, and possibly a radiologist.&#x000a0;Nurses are also vital members of the interprofessional group as they will assist with the education of the patient and family. In the postoperative period for pain and wound infection, the pharmacist will ensure the patient is on the right analgesics and antibiotics. The radiologist plays a vital role in determining the extent of involvement, perineural invasion, and presence of intraorbital tumors.&#x000a0;Clinical practice guidelines have been established in dermatology literature developed following an exhaustive review of current medical literature from peer-reviewed journals to determine appropriate management based upon current evidence.<xref ref-type="bibr" rid="article-25103.r4">[4]</xref>&#x000a0;[Level 1]</p>
      </sec>
      <sec id="article-25103.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25103&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25103">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/microcystic-adnexal-carcinoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25103">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25103/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25103">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25103.s19">
        <title>References</title>
        <ref id="article-25103.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diago</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Requena</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Traves</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Requena</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Solid Microcystic Adnexal Carcinoma on the Thigh: An Unusual Location.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-124</page-range>
            <pub-id pub-id-type="pmid">31436574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerall</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Sippel</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Yracheta</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Microcystic Adnexal Carcinoma: A Rare, Commonly Misdiagnosed Malignancy.</article-title>
            <source>Mil Med</source>
            <year>2019</year>
            <month>Dec</month>
            <day>01</day>
            <volume>184</volume>
            <issue>11-12</issue>
            <fpage>948</fpage>
            <page-range>948-950</page-range>
            <pub-id pub-id-type="pmid">31125069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gordon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosman</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Council</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Microcystic Adnexal Carcinoma: A Review of the Literature.</article-title>
            <source>Dermatol Surg</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>1012</fpage>
            <page-range>1012-1016</page-range>
            <pub-id pub-id-type="pmid">28654578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Worley</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Behshad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bichakjian</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Bolotin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bordeaux</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Bradshaw</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cartee</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Council</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Eisen</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Golda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>SIB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lacutoure</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Leitenberger</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Minkis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nehal</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Neuhaus</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ozog</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Samie</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Sobanko</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Somani</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Stebbins</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tse</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Waldman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zeitouni</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Ramsay</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Poon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma: Informed by a Systematic Review.</article-title>
            <source>JAMA Dermatol</source>
            <year>2019</year>
            <month>Sep</month>
            <day>01</day>
            <volume>155</volume>
            <issue>9</issue>
            <fpage>1059</fpage>
            <page-range>1059-1068</page-range>
            <pub-id pub-id-type="pmid">31268498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inskip</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magee</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Microcystic adnexal carcinoma of the cheek-a case report with dermatoscopy and dermatopathology.</article-title>
            <source>Dermatol Pract Concept</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-6</page-range>
            <pub-id pub-id-type="pmid">25692080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shinohara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ansai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Saeki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopic findings of microcystic adnexal carcinoma.</article-title>
            <source>Eur J Dermatol</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>516</fpage>
            <page-range>516-8</page-range>
            <pub-id pub-id-type="pmid">26693638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calder&#x000f3;n-Castrat</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Rom&#x000e1;n-Curto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Santos-Briz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-L&#x000f3;pez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Microcystic adnexal carcinoma mimicking basal cell carcinoma.</article-title>
            <source>JAAD Case Rep</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>492</fpage>
            <page-range>492-494</page-range>
            <pub-id pub-id-type="pmid">29034297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kakkar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sulaiman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ramam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopic pitfall: Microcystic adnexal carcinoma mimicking basal cell carcinoma.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2020</year>
            <season>Mar-Apr</season>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>202</fpage>
            <page-range>202-205</page-range>
            <pub-id pub-id-type="pmid">31997790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Passaro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Scheuller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McCalmont</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Grekin</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome.</article-title>
            <source>Arch Dermatol</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>136</volume>
            <issue>11</issue>
            <fpage>1355</fpage>
            <page-range>1355-9</page-range>
            <pub-id pub-id-type="pmid">11074698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Tishler</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A&#x000a0;Case&#x000a0;Report and Review of the Literature.</article-title>
            <source>Adv Radiat Oncol</source>
            <year>2020</year>
            <season>Mar-Apr</season>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>301</fpage>
            <page-range>301-310</page-range>
            <pub-id pub-id-type="pmid">32280832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25103.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wetter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Microcystic adnexal carcinoma: a diagnostic and therapeutic challenge.</article-title>
            <source>Dermatol Ther</source>
            <year>2008</year>
            <season>Nov-Dec</season>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>452</fpage>
            <page-range>452-8</page-range>
            <pub-id pub-id-type="pmid">19076623</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
